Kevin F. McLaughlin, SVP, CFO and Treasurer at ACCELERON PHARMA INC (XLRN), sold 7,282 shares at $124.47 ($899K) on 2021-01-04, disclosed to the SEC on 2021-01-06.
Seasonal sale ($899k) by SVP, CFO and Treasurer — this insider has traded XLRN in January in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $123.49 | 600 | $74K | 8.2% |
| 2 | $123.54 | 800 | $99K | 11.0% |
| 3 | $124.28 | 713 | $89K | 9.9% |
| 4 | $124.28 | 713 | $89K | 9.9% |
| 5 | $124.31 | 624 | $78K | 8.6% |
| 6 | $124.45 | 300 |
| $37K |
| 4.2% |
| 7 | $124.47 | 667 | $83K | 9.2% |
| 8 | $124.47 | 667 | $83K | 9.2% |
| 9 | $125.49 | 200 | $25K | 2.8% |
| 10 | $120.43 | 700 | $84K | 9.4% |
| 11 | $121.89 | 499 | $61K | 6.8% |
| 12 | $121.89 | 499 | $61K | 6.8% |
| 13 | $122.85 | 296 | $36K | 4.0% |
| 14 | $123.50 | 4 | $494 | 0.1% |
| Total | $123.45 avg | 7,282 | $899K | 100% |
| Filing → |
| VCEL | SELL | 2026-02-13 | $243K | — | Filing → |
| IVVD | BUY | 2025-11-20 | $125K | — | Filing → |
| VCEL | SELL | 2025-11-12 | $270K | — | Filing → |